1. Home
  2. OCSL vs SPTX Comparison

OCSL vs SPTX Comparison

Compare OCSL & SPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oaktree Specialty Lending Corporation

OCSL

Oaktree Specialty Lending Corporation

HOLD

Current Price

$13.11

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo Seaport Therapeutics Inc. Common Stock

SPTX

Seaport Therapeutics Inc. Common Stock

N/A

Current Price

$23.87

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OCSL
SPTX
Founded
2007
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
2007
2026

Fundamental Metrics

Financial Performance
Metric
OCSL
SPTX
Price
$13.11
$23.87
Analyst Decision
Hold
Analyst Count
4
0
Target Price
$12.63
N/A
AVG Volume (30 Days)
561.2K
104.0K
Earning Date
05-05-2026
N/A
Dividend Yield
12.73%
N/A
EPS Growth
N/A
N/A
EPS
0.20
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.31
N/A
P/E Ratio
$65.55
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.63
$17.59
52 Week High
$14.31
$26.32

Technical Indicators

Market Signals
Indicator
OCSL
SPTX
Relative Strength Index (RSI) 65.39 61.29
Support Level $12.31 $18.72
Resistance Level $13.86 N/A
Average True Range (ATR) 0.29 1.45
MACD 0.06 0.10
Stochastic Oscillator 92.04 62.75

Price Performance

Historical Comparison
OCSL
SPTX

About OCSL Oaktree Specialty Lending Corporation

Oaktree Specialty Lending Corp is a specialty finance company. The company provides lending services and invests in small and mid-sized companies. The company's investment objective is to maximize its portfolio's total return by generating current income from debt investments, and to a lesser extent, capital appreciation from equity investments. The company provides customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets. The company operates as a single reportable segment and derives revenues from investing in originated loans and other securities, including broadly syndicated loans, of U.S. private companies and manages the business on a consolidated basis.

About SPTX Seaport Therapeutics Inc. Common Stock

Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.

Share on Social Networks: